Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience-Reference-Cited by-同舟云学术

Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

Published:2006-05-01 Issue:13 Volume:24 Page:e20-e22
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Lamers Cor H.J.¹,Sleijfer Stefan¹,Vulto Arnold G.¹,Kruit Wim H.J.¹,Kliffen Mike¹,Debets Reno¹,Gratama Jan W.¹,Stoter Gerrit¹,Oosterwijk Egbert²

Affiliation:

1. Departments of Medical Oncology, Pharmacy, and Pathology, Erasmus University Medical Center–Daniel den Hoed Cancer Center, Rotterdam, the Netherlands

2. Department of Experimental Urology, University Medical Center, Nijmegen, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.05.9964

Reference11 articles.

1. Weijtens MEM, Willemsen RA, Valerio D, et al: Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. J Immunol 157:836,1996-843,

2. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer

3. Lamers CHJ, Willemsen RA, van Elzakker P, et al: Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: Implications for clinical immunogene therapy of cancer. Cancer Gene Ther 10.1038/sj.cgt.7700916 (Epub ahead of print on November 11, 2005)

4. Parallel Detection of Transduced T Lymphocytes After Immunogene Therapy of Renal Cell Cancer by Flow Cytometry and Real-Time Polymerase Chain Reaction: Implications for Loss of Transgene Expression

5. Divgi CR, O'Donoghue JA, Welt S, et al: Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer. J Nucl Med 45:1412,2004-1421,

Cited by 730 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationally designed approaches to augment CAR-T therapy for solid tumor treatment;Bioactive Materials;2024-03

2. Evolution of cell therapy for renal cell carcinoma;Molecular Cancer;2024-01-09

3. Chimeric Antigen Receptor Therapy in Acute Myeloid Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. Injectable Supramolecular Hydrogels for In Situ Programming of Car‐T Cells toward Solid Tumor Immunotherapy;Advanced Materials;2023-12-04

5. The landscape of cancer research and cancer care in China;Nature Medicine;2023-12